Synopsis: Beatty, Haas, and colleagues report antitumor activity in two patients treated with autologous T cells transfected with mRNA encoding a chimeric antigen receptor that recognizes mesothelin and contains the CD3-z and 4-1BB costimulatory domains (CARTmeso). The shortlived CARTmeso cells induced novel antiself antibodies and a broadly directed epitope spreading. 
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ABOUT THE COVER
The cover image is an artistic rendition of the complex biologic features of the CD4 þ T-cell lineage and their contribution to tumor immunity. In response to developmental and environmental cues, CD4 þ T cells differentiate into multiple subsets to orchestrate a broad range of effector activities during the initiation, expansion, and memory phase of a host immune response against pathogenic invasion, in regulating autoimmunity, and in shaping antitumor immunity.
Six major CD4 þ T-cell subsets have been characterized with antitumor and/or protumor activity: CD4-CTL and T H 1 cells express immune molecules that promote tumor killing. T FH , T H 2, and T H 17 cells have both antitumor and protumor activities. In the early 1970s, T cells were thought to be a homogenous population of lymphocytes that were not B cells. Dr. Cantor's studies indicated that the thymus gave rise to two major lineages of T cells (T-helper [T H ] and T-cytotoxic [T C ]), which recognized the MHC class II and class I molecules, respectively, and which were equipped to mediate distinct immunologic functions before overt encounter with antigen. These experiments were based on the idea that the pattern of proteins expressed on the cell surface could be used to separate and define the developmental and functional components of the immune system. The Cantor laboratory used this approach to dissect cellmediated immunity into its cellular components, to isolate natural killer (NK) cells, and to correlate T-cell surface phenotype with function and MHC restriction at the clonal level.
Recent studies from the Cantor lab have begun to define a lineage of CD8 þ regulatory T cells (Treg) that are genetically programmed to inhibit the development of autoimmune disease and to regulate antitumor immunity via suppression of the activation and expansion of follicular helper T cells (T FH ). The Cantor lab has defined an interaction between dendritic cells and T cells that regulates the differentiation of T H cell subsets after infection and have defined an inhibitory interaction between NK cells and autoreactive T cells that may regulate autoimmune disease. To request permission to re-use all or part of this article, contact the AACR Publications Department at
